-
Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action
Facente SN, Grinstein R, Broussard J, Shost J, Azari S, Siruno J, Jimenez JA, Luetkemeyer AF, Burk K. Public Health Reports. 2022 Apr 9. doi: 10.1177/00333549221083741.
-
Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review
Facente SN, Grebe E, Maher AD, Fox D, Scheer S, Mahy M, Dalal S, Lowrance D, Marsh K. JMIR Public Health Surveillance. 2022 Mar 11; 8(3):e34410.
-
Factors Associated with Stigma Related to HIV Pre-Exposure Prophylaxis (PrEP) Use Among Men Who Have Sex With Men (MSM)
Bhatta DN, Hecht J, Facente SN. Sexually Transmitted Infections. 2022 Feb 4:sextrans-2021-055296.
-
Impact of Racial Categorization on Effect Estimates: An HIV Stigma Analysis
Facente SN, Lam-Hine T, Bhatta DN, Hecht J. American Journal of Epidemiology. 2022 Mar 24; 191(4): 689-695.
-
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
Facente SN, Reiersen AM, Lenze EJ, Boulware DR, Klausner JD. Drugs. 2021 Dec; 81(18): 2081-2089.
-
Are You Really the Doctor? Physician Experiences with Gendered Microaggressions from Patients
Ahmad SR, Ahmad TR, Balasubramanian V, Facente S, Kin C, Girod S. Journal of Women's Health. 2021 Nov 5. doi: 10.1089/jwh.2021.0169.
-
Examining the impact of the Golden Compass clinical care program for older people with HIV: A qualitative study
Tan JY, Greene M, Blat C, Albers A, Grochowski J, Oskarsson J, Shiels M, Hsue P, Havlir D, Gandhi M, Myers J. AIDS & Behavior. 2022 May;26(5):1562-1571.
-
Hepatitis C Mortality Trends in San Francisco: Can we Reach Elimination Targets?
Mirzazadeh A, Facente SN, Burk K, Kahn JG, Morris MD; End Hep C SF. Annals of Epidemiology. 2022 Jan; 65: 59-64.
-
Feasibility and Effectiveness of Daily Temperature Screening to Detect COVID-19 in a Prospective Cohort at a Large Public University
Facente SN, Hunter LA, Packel LJ, Li Y, Harte A, Nicolette G, McDevitt S, Petersen M, Reingold AL. BMC Public Health. 2021 Sep 16; 21(1): 1693.
-
What Surgeons Want: Access to Online Surgical Education and Peer-to-Peer Counseling - a Qualitative Study
Häberle AD, Nath R, Facente SN, Albers AE, Girod S. Craniomaxillofacial Trauma & Reconstruction. 2021 Sep; 14(3): 189-195.
-
Hepatitis C Care Cascades for 3 Populations at High Risk: Low-income Trans Women, Young People Who Inject Drugs, and Men Who Have Sex With Men and Inject Drugs
Facente SN, Patel S, Hecht J, Wilson E, McFarland W, Page K, Vickerman P, Fraser H, Burk K, Morris MD. Clinicial Infectious Diseases. 2021 Sep 15;73(6):e1290-e1295.
-
Psychosocial Determinants of HIV Stigma Among Men Who Have Sex With Men in San Francisco, CA
Bhatta DN, Hecht J, Facente SN. International Journal of Environmental Research and Public Health. 2021; 18(5):8031.
-
Bovine Ownership and Reduced Pulmonary Tuberculosis Risk in
Nepal: A Case–control Study
Bates MN, Pope K, Sijali TR, Albers AE, Verma SC. Zoonoses Public Health. 2021; 00:1-8.
-
Piloting an Integrated SARS-CoV-2 Testing and Data System for Outbreak Containment among College Students: A Prospective Cohort Study
Packel L, Reingold A, Hunter L, Facente SN, Li Y, Harte A, Nicolette G, Urnov FD, Lu M, Petersen M. PLoS ONE. 2021; 16(1): e0245765.
-
Estimated Dates of Detectable Infection (EDDIs) as an Improvement upon Fiebig Staging for HIV Infection Dating
Facente SN, Grebe E, Pilcher CD, Busch MP, Murphy G, Welte A. Epidemiology & Infection. 2020; 148: e53.
-
Smoking-Cessation Interventions in Appalachia: A Systematic Review and Meta-Analysis
Gupta S, Scheuter C, Kundu A, Bhat N, Cohen A, Facente SN. American Journal of Preventive Medicine. 2020; 58(2): 261-269.
-
Interpreting HIV Diagnostic Histories into Infection Time Estimates: Analytical Framework and Online Tool
Grebe E, Facente SN, Bingham J, Pilcher CD, Powrie A, Gerber J, Priede G, Chibawara T, Busch MP, Murphy G, Kassanjee R, Welte, A, and the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). BMC Infectious Diseases. October 26, 2019, 18(894).
-
Challenges to the Performance of Current HIV Diagnostic Assays and the Need for Centralized Specimen Archives: a Review of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) Repository
Facente SN, Busch MP, Grebe E, Pilcher CD, Welte A, Rice B, Murphy G. Gates Open Research. July 23, 2019, 3(1511). doi: https:// doi.org/10.12688/gatesopenres.13048.1.
-
Performance Comparison of the Maxim and Sedia Limiting Antigen Avidity Assays for Incidence Surveillance
Sempa JB Welte A, Busch MP, Hall J, Hampton D, Keating SM, Facente SN, Marson K, Parkin N, Pilcher CD, Murphy G, Grebe E; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Plos ONE. July 26, 2019, 14(7): e0220345.
-
Household Fuel Use and Latent Tuberculosis Infection in a Nepali Population
Albers AE, Pope K, Sijali TR, Subramanya SH, Verma SC, Bates MC. Environmental Research. June 2019, 173: 69-76.
-
A Generalizable Method for Estimating Duration of HIV Infections Using Clinical Testing History and HIV Results
Pilcher CD, Porco TC, Facente SN, Grebe E, Delaney KP, Masciotra S, Kassanjee R, Busch MP, Murphy G, Owen SW, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). AIDS. June 1, 2019, 33(7): 1231-1240.
-
The Genetic Interaction between HIV and the Antibody Repertoire
Strauli N, Fryer EK, Pham O, Abdel-Mohsen M, Facente SN, Pilcher C, Pennings P, Pillai S, Hernandez RD. The genetic interaction between HIV and the antibody repertoire. bioRxiv. May 23, 2019. doi:10.1101/646968.
-
New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care
Facente SN, Burk K, Eagen K, Mara ES, Smith AA, Lynch CS. Infectious Disease Clinics of North America. June 2018, 32(2): 313-322.
-
Localized US Efforts to Eliminate Hepatitis C
Gaudino A, Gay B, Garmon C, Selick M, Vreeland R, Burk K, Huriaux E, Facente SN, Luetkemeyer A, Waters P, Graham CS. Infectious Disease Clinics of North America. June 2018, 32(2): 293-311.
-
Estimated Hepatitis C Prevalence and Key Population Sizes in San Francisco: A Foundation for Elimination
Facente SN, Grebe E, Burk K., Morris MD, Murphy E, Mirzazadeh A, Smith A, Sanchez M, Evans J, Nishimura A, Raymond HF. PLoS One. April 11, 2018, 13(4): e0195575.
-
Computational Analysis of Antibody Dynamics Identifies Recent HIV-1 Infection
Seaton KE, Vandergrift NA, Deal AW, Rountree W, Bainbridge J, Grebe E, Anderson DA, Sawant S, Shen X, Yates NL, Denny TN, Liao H-X, Haynes BF, Robb ML, Parkin N, Santon BR, Garrett N, Price MA, Naniche D, Duerr AC, Keating S, Hampton D, Facente S, Marson K, Welte A, Pilcher CD, Cohen MS, Tomaras GD. JCI Insight, December 22, 2017; 2(24): e94355.
-
Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms
Grebe E, Welte A, Hall J, Keating SM, Facente SN, Marson K, Martin JN, Little SJ, Price MA, Kallas EG, Busch MP, Pilcher CD, Murphy G; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). J Acquir Immune Defic Syndr, December 15, 2017; 76(5):547-555.
-
HIV Antibody Level as a Marker of HIV Persistence and Low Level Viral Replication
Keating SM, Pilcher CD, Jain V, Lebedeva M, Hampton D, Abdel-Mohsen M, Deng X, Murphy G, Welte A, Facente SN, Hecht F, Deeks SG, Pillai SK, Busch MP. Journal of Infectious Diseases. 2017, 216:72–81.
-
Comparison of Cross-sectional HIV Incidence Assay Results from Dried Blood Spots and Plasma
Schlusser KE, Pilcher C, Kallas EG, Santos BR, Deeks SG, Facente S, Keating SM, Busch MP, Murphy G, Welte A, Quinn T, Eshleman SH, Laeyendecker O. PLoS One, February 23, 2017, 12(2):e0172283.
-
Moving Towards a Reliable HIV Incidence Test – Current Status, Resources Available, Future Directions and Challenges Ahead
Murphy G, Pilcher CD, Keating SM, Kassanjee R, Facente SN, Welte A, Grebe E, Marson K, Busch MP, Dailey P, Parkin N, Osborn J, Ongarello S, Marsh K, Garcia-Calleja JM; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA), Foundation for Innovative New Diagnostics, UNAIDS, and the WHO Technical Working Group. Epidemiology & Infection, 2017 Apr, 145(5): 925-941.
-
Performance of the Bio-Rad Geenius HIV-1/2 Supplemental Assay in Detecting ‘Recent’ HIV Infection and Calculating Population Incidence
Keating SM, Kassanjee R, Lebedeva M, Facente SN, MacArthur JC, Grebe E, Murphy G, Welte A, Martin JN, Little S, Price MA, Kallas EG, Busch MP, Pilcher CD; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). J Acquir Immune Defic Syndr, December 15, 2016, 73(5): 581-588.
-
Viral Load Criteria and Threshold Optimization to Improve HIV Incidence Assay Characteristics – a CEPHIA Analysis
Kassanjee R, Pilcher CD, Busch MP, Murphy G, Facente SN, Keating SM, McKinney E, Marson K, Price MA, Martin JN, Little SJ, Hecht FM, Kallas EG, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). AIDS, 2016, 30:2361-2371.
-
Using a Multitest Algorithm to Improve the Positive Predictive Value of Rapid HIV Testing and Linkage to HIV Care in Nonclinical HIV Test Sites
Delaney KP, Rurangirwa J, Facente S, Dowling T, Janson M, Knoble T, Vu A, Hu YW, Kerndt PR, King J, Scheer S. J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):78-86.
-
Independent Assessment of Candidate HIV Incidence Assays on Specimens in the CEPHIA Repository
Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, and Murphy G. AIDS, October 23, 2014, 28(16): 2439-2449.
-
Performance of Rapid Point-of-Care and Laboratory Tests for Acute and Established HIV Infection in San Francisco
Pilcher CD, Louie B, Facente S, Keating S, Hackett J, Vallari A, Hall C, Dowling T, Busch MP, Klausner JD, Hecht FM, Liska S, Pandori MW. PLoS ONE, December 2013, 8(12): e80629. doi:10.1371/journal.pone.0080629.
-
Performance of Risk-Based Criteria for Targeting Acute HIV Screening in San Francisco
Facente, SN, Pilcher, CD, Hartogensis, WE, Klausner, JD, Philip, SS, Louie, B, Christopoulos, KA, Dowling T, and Colfax GN. PLoS ONE, July 2011, 6(7): e21813. doi:10.1371/journal.pone.0021813
-
From Questionnaire to Conversation: A Structural Intervention to Improve HIV Test Counseling
Sheon N, Lee S-H, and Facente SN. Patient Education and Counseling, December 2010, 81(3): 468-475.
-
False Positive Rate of Rapid Oral Fluid HIV Tests Increases as Kits Near Expiration Date
Facente, SN, Dowling, T, Vittinghoff, E, Sykes, DL, and Colfax, GN. PLoS ONE, December 2009, 4(12): e8217. doi:10.1371/journal.pone.0008217. PLoS ONE, December 2009, 4(12): e8217. doi:10.1371/journal.pone.0008217
-
Addressing Food Security Through Public Policy Action in a Community-Based Participatory Research Partnership
Breckwich-Vásquez, V, Lanza, D, Hennessey-Lavery, S, Facente, S, Halpin, HA, and Minkler, M. Health Promotion Practice, October 2007, 8(4): 342-349.
-
Sowing the Seeds for Sustainable Change: A Community-Based Participatory Research Partnership for Health Promotion in Indiana, USA and its Aftermath
Minkler, M, Breckwich-Vásquez, V, Rains-Warner, J, Steussey, H, Facente, SN. Health Promotion International, December 2006, 21(4): 293-300.
-
Post-marketing Surveillance of OraQuick Whole Blood and Oral Fluid Rapid HIV Testing
Wesolowski, LG, MacKellar, DA, Facente, SN, Dowling, T, Ethridge, SF, Zho, JH, and Sullivan, PS. AIDS, August 2006, 20(12):1661-1666.